ArticleLife (Basel, Switzerland)2026
Identification of Maternal Serum Longitudinal Signatures Through Profiling of 96 Cytokines.
Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Changes in the maternal serum cytokine landscape occur throughout pregnancy, representing immune adaptations and modifications to support a healthy pregnancy. A better understanding of normal cytokine patterns can help improve the management of pregnancy and potentially predict complications. Using maternal serum samples collected at four different timepoints from 29 subjects, we characterized the longitudinal serum cytokine patterns throughout normal pregnancy with a multiplex ELISA of 96 cytokines. Based on unsupervised principal component analyses of the 96-cytokine data, we developed an integrated panel that incorporated the data of 21 key cytokines. This integrated immune signature allowed us to distinguish serum samples collected at different stages of healthy pregnancy and evaluate their chemotactic properties in vitro. We also evaluated the potential of using integrated cytokine scores for identifying pathological condition like preeclampsia before clinical signs are presented. This study explored new approaches of developing serum biomarker panels for immune profiling and early detection of pathological conditions during pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.